Abstract

BackgroundVaccinating children against influenza has shown both direct and indirect beneficial effects. However, despite being offered free of charge, childhood influenza vaccine coverage in Israel has been low. Our objective was to evaluate the factors associated with childhood influenza vaccination in Israel.MethodsA cross-sectional language-specific telephone survey was conducted among adults 18 years or older, to examine childhood influenza vaccination practices and their associations with socio-demographic and relevant health variables. We further explored the reasons for these practices among parents. Multivariate logistic regression was used to identify factors associated with childhood influenza vaccine acceptance.ResultsOf a total of 6518 individuals contacted by mobile phone, 1165 eligible parents, ≥18 years old with children 1–18 years of age, were interviewed, and 1040 of them completed the survey successfully. Overall, factors associated with childhood influenza vaccination were younger child’s age, influenza vaccination of other family members and belonging to the Arab population group. No association was found between childhood influenza vaccination and routine childhood vaccine uptake. Several of the parents’ reasons for vaccine acceptance - preventing influenza or its transmission, awareness regarding the need for influenza vaccination and receipt of invitation to get vaccinated - differed significantly between Jewish and Arab parents. Several reasons reported by parents for not vaccinating children against influenza, indicated a likelihood to accept influenza vaccine outreach efforts. Such reasons were reported by 27.5% of Jewish parents and 37.5% of Arab parents.ConclusionsWe found that certain demographic factors were associated with childhood influenza vaccination in Israel. Several reasons described by the parent for not vaccinating their children indicate that outreach efforts are likely to increase childhood influenza vaccination. Addressing population group-specific needs is recommended to optimize the success of influenza vaccine outreach efforts.

Highlights

  • Vaccinating children against influenza has shown both direct and indirect beneficial effects

  • A total of 89 eligible individuals who reported not knowing whether their child had received the influenza vaccine in the influenza season preceding the day of the survey, were not further interviewed, and a total of 36 interviews were cancelled due to internal inconsistencies or incoherence

  • The final sample for analysis included a total of 1040 participants, 586 from the Jewish population group and 454 from the Arab population group

Read more

Summary

Introduction

Vaccinating children against influenza has shown both direct and indirect beneficial effects. Vaccinating children against influenza has shown both direct and indirect beneficial effects, being associated with a decrease in influenza-related deaths [6], as well as indirect protection in households [7] and communities [8,9,10]. Influenza vaccine effectiveness against death in children six months to 17 years old was found to reach up to 80% [6]; fewer healthcare visits. The inactivated trivalent (TIV) and quadrivalent (QIV) influenza vaccines, as well as the live attenuated influenza vaccines (LAIV) are registered for use in Israel. The inactivated influenza vaccines are offered at no cost to the public Both the inactivated and the live attenuated influenza vaccines have been available for use, with the LAIV available for a fee. Following the debate regarding the LAIV effectiveness in the 2015/16 season [12, 13], the inactivated influenza vaccine (TIV or QIV) has become the vaccine of choice for the 2016/2017 and 2017/2018 influenza seasons [11]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call